M. Luscombe

Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.

M. Knowles, T. Habuchi, P. Elder, 1998 .

Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.

P. Charlton, I. Dale, R. Callaghan, 1998, British Journal of Cancer.

Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.

M. Knowles, T. Habuchi, P. Elder, 1999, Genomics.

A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity.

M. Luscombe, P. Twentyman, P. Twentyman, 1987, British Journal of Cancer.

Allelic loss on chromosomes 8p, 22q and 18q (DCC) in human prostate cancer

J. Neoptolemos, M. Knowles, D. Morton, 1996, International journal of cancer.

Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.

Patricia A. Elder, M. Knowles, T. Habuchi, 1998, Genomics.

Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.

M. Clemens, M. Luscombe, N. Sharp, 1989, Oncogene.